Venture capital firm

Norwich Ventures

Specialist venture capital firm investing in early-stage medtech entrepreneurs

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Norwich Ventures is a specialist venture capital firm founded in 2004. It concentrates on early-stage medical technology and backs entrepreneurs who are tackling large unmet medical needs. It takes a long-term view of each investment.

What Norwich Ventures does

Seed capital: first funding for medtech companies at the earliest stage.
Early-stage rounds: follow-on support as a company develops its product.
Long-term partnership: a patient approach to each investment.
Proof-of-concept focus: the firm looks for technology with a quick route to showing that an idea works.

Who it serves

Entrepreneurs developing new medical technologies. The firm is not tied to one field of medicine and has supported companies in electrophysiology, genomics and women's health.

Key facts

Founded: 2004
Stage: seed and early stage
Focus: medtech
Approach: open to any area of medicine where new technology can solve a big healthcare problem

Summary written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

Norwich Ventures is ranked on 2 TrustList rankings: #10 on 1 and #18 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Norwich Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#10of 291
Seed stage
It is one of 7 here listing healthtech.
Of the top 54 here, 19 also cover series a and 18 also cover pre seed; 8 also work in Silicon Valley and 7 also work in San Francisco.
Behind Elevation Capital, ahead of Startup Capital Ventures.
#18of 147
Healthtech investors
It is one of 13 here listing seed stage.
Of the top 64 here, 16 also cover partners and 14 also cover biotech; 10 also work in New York City and 7 also work in Boston.
Behind Karista, ahead of Linden Capital Partners.